Peter Josef Flor

Title: The Innovations of Peter Josef Flor

Introduction

Peter Josef Flor is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of metabotropic glutamate receptors. With a total of 3 patents to his name, Flor's work has implications for various therapeutic applications.

Latest Patents

Flor's latest patents include innovations related to human metabotropic glutamate receptors. One of his inventions focuses on the human metabotropic glutamate receptor subtype mGluR7b. This invention provides purified human metabotropic glutamate receptors, compositions comprising such receptors, and nucleic acids that encode such receptors. Another significant patent pertains to human metabotropic glutamate receptor 7 subtypes. This invention relates to human metabotropic glutamate receptor (hmGluR) proteins, isolated nucleic acids coding therefor, host cells producing the proteins of the invention, methods for the preparation of such proteins, nucleic acids and host cells, and uses thereof.

Career Highlights

Peter Josef Flor is currently associated with Novartis Corporation, a leading global healthcare company. His work at Novartis has allowed him to further his research and development in the field of pharmaceuticals and biotechnology.

Collaborations

Flor has collaborated with several professionals in his field, including Rainer Kuhn and Kristin Lindauer. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Peter Josef Flor's contributions to the field of biotechnology through his patents on metabotropic glutamate receptors highlight his innovative spirit and dedication to advancing medical science. His work continues to influence the development of new therapeutic strategies.